Bioactive Compound Details

BioIDbio1996
NameDARIFENACIN
ChEMBL IDCHEMBL1346
Molecular FormulaC28H30N2O2
Molecular Weight426.56
Molecular Weight (Monoisotopic)426.2307
TypeSmall molecule
Max PhasePhase 4
Target IDTar12
Target NameToll-like receptor 9 (TLR9)
SynonymsDARIFENACIN|DARIFENACIN EXTENDED RELEASE|DARIFENACINA|DARIFENACINE|UK-88525
SmilesNC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
InchiInChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1
Inchi KeyHXGBXQDTNZMWGS-RUZDIDTESA-N
Molecular SpeciesBASE
Targets89.0
Bioactivities199.0
Np Likeness Score-0.56
Records Key['1', 'Darifenacin', 'Darifenacin', 'DARIFENACIN', 'Darifenacin', '3', 'Darifenacin', '3', '3', 'Darifenacin', 'SID50113277', 'LABA', 'Darifenacin', '2', 'darifenacin', 'Darifenacin', '3453', '4', 'Darifenacin', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'COVC-1211756174', 'darifenacin', 'BA1001186']
Records Name['Indacaterol', '(S)-2-(1-(3-(2,3-dihydrobenzofuran-5-yl)propyl)pyrrolidin-3-yl)-2,2-diphenylacetamide', 'Darifenacin', 'DARIFENACIN', '2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide (Darifenacin)', '2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide', '2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide', 'Indacaterol', 'Indacaterol', 'Darifenacin', 'SID50113277', 'Indacaterol', 'Darifenacin', 'Darifenacin', 'darifenacin', 'Darifenacin', None, '(R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one', 'Darifenacin', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'darifenacin', 'DARIFENACIN']
Withdrawn FlagFalse
Orphan0

Molecular Structure

2D Molecular Structure